BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

899 related articles for article (PubMed ID: 11917091)

  • 1. Function and genetics of dystrophin and dystrophin-related proteins in muscle.
    Blake DJ; Weir A; Newey SE; Davies KE
    Physiol Rev; 2002 Apr; 82(2):291-329. PubMed ID: 11917091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Utrophin upregulation for treating Duchenne or Becker muscular dystrophy: how close are we?
    Miura P; Jasmin BJ
    Trends Mol Med; 2006 Mar; 12(3):122-9. PubMed ID: 16443393
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dissecting the signaling and mechanical functions of the dystrophin-glycoprotein complex.
    Judge LM; Haraguchiln M; Chamberlain JS
    J Cell Sci; 2006 Apr; 119(Pt 8):1537-46. PubMed ID: 16569668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dysferlin and the plasma membrane repair in muscular dystrophy.
    Bansal D; Campbell KP
    Trends Cell Biol; 2004 Apr; 14(4):206-13. PubMed ID: 15066638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Muscular dystrophies related to the cytoskeleton/nuclear envelope.
    Nowak K; McCullagh K; Poon E; Davies KE
    Novartis Found Symp; 2005; 264():98-111; discussion 112-7, 227-30. PubMed ID: 15773750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation and functional significance of utrophin expression at the mammalian neuromuscular synapse.
    Gramolini AO; Wu J; Jasmin BJ
    Microsc Res Tech; 2000 Apr; 49(1):90-100. PubMed ID: 10757882
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Dystrophin and dystrophin-associated proteins. Their evaluation at the neuromuscular pathology laboratory].
    Navarro C
    Rev Neurol; 1999 Jan 16-31; 28(2):154-8. PubMed ID: 10101784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Defective membrane repair in dysferlin-deficient muscular dystrophy.
    Bansal D; Miyake K; Vogel SS; Groh S; Chen CC; Williamson R; McNeil PL; Campbell KP
    Nature; 2003 May; 423(6936):168-72. PubMed ID: 12736685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Restoration of all dystrophin protein interactions by functional domains in trans does not rescue dystrophy.
    Gardner KL; Kearney JA; Edwards JD; Rafael-Fortney JA
    Gene Ther; 2006 May; 13(9):744-51. PubMed ID: 16307000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Etiology and pathogenesis of the muscular dystrophies.
    Van den Bergh PY; Tomé FM; Fardeau M
    Acta Neurol Belg; 1995; 95(3):123-41. PubMed ID: 7484050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Updates in muscular dystrophies].
    Erazo-Torricelli R
    Rev Neurol; 2004 Nov 1-15; 39(9):860-71. PubMed ID: 15543503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma membrane cytoskeleton of muscle: a fine structural analysis.
    Watkins SC; Cullen MJ; Hoffman EP; Billington L
    Microsc Res Tech; 2000 Feb 1-15; 48(3-4):131-41. PubMed ID: 10679961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of a NOS transgene in dystrophin-deficient muscle reduces muscle membrane damage without increasing the expression of membrane-associated cytoskeletal proteins.
    Tidball JG; Wehling-Henricks M
    Mol Genet Metab; 2004 Aug; 82(4):312-20. PubMed ID: 15308129
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic strategies for Duchenne and Becker dystrophies.
    Voisin V; de la Porte S
    Int Rev Cytol; 2004; 240():1-30. PubMed ID: 15548414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological strategies for muscular dystrophy.
    Khurana TS; Davies KE
    Nat Rev Drug Discov; 2003 May; 2(5):379-90. PubMed ID: 12750741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improvement of calcium handling and changes in calcium-release properties after mini- or full-length dystrophin forced expression in cultured skeletal myotubes.
    Marchand E; Constantin B; Balghi H; Claudepierre MC; Cantereau A; Magaud C; Mouzou A; Raymond G; Braun S; Cognard C
    Exp Cell Res; 2004 Jul; 297(2):363-79. PubMed ID: 15212940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Autosomal recessive limb-girdle muscular dystrophy].
    Hernández-Caballero ME; Miranda-Duarte A; Escobar-Cedillo RE; Villegas-Castrejon H
    Rev Neurol; 2010 Oct; 51(8):489-96. PubMed ID: 20925031
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of ARC, apoptosis repressor interacting with CARD, in normal and dystrophin-deficient skeletal muscle.
    Abmayr S; Crawford RW; Chamberlain JS
    Hum Mol Genet; 2004 Jan; 13(2):213-21. PubMed ID: 14645204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and molecular studies in Duchenne muscular dystrophy.
    Emery AE
    Prog Clin Biol Res; 1989; 306():15-28. PubMed ID: 2662210
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Severe muscular dystrophy in mice that lack dystrophin and alpha7 integrin.
    Rooney JE; Welser JV; Dechert MA; Flintoff-Dye NL; Kaufman SJ; Burkin DJ
    J Cell Sci; 2006 Jun; 119(Pt 11):2185-95. PubMed ID: 16684813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 45.